CVS Health Co. (NYSE:CVS) Shares Purchased by Daymark Wealth Partners LLC

Daymark Wealth Partners LLC boosted its position in shares of CVS Health Co. (NYSE:CVS) by 37.6% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 90,697 shares of the pharmacy operator’s stock after acquiring an additional 24,792 shares during the quarter. Daymark Wealth Partners LLC’s holdings in CVS Health were worth $5,703,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Ables Iannone Moore & Associates Inc. purchased a new position in CVS Health during the fourth quarter valued at approximately $32,000. Creekmur Asset Management LLC acquired a new position in CVS Health during the fourth quarter worth $34,000. Steph & Co. boosted its position in shares of CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 288 shares during the last quarter. Kapitalo Investimentos Ltda purchased a new position in CVS Health during the fourth quarter worth about $36,000. Finally, Scarborough Advisors LLC acquired a new position in CVS Health in the 4th quarter valued at about $37,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. Barclays reduced their price target on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 8th. TD Cowen upgraded CVS Health from a “hold” rating to a “buy” rating and increased their price target for the stock from $59.00 to $85.00 in a report on Friday, October 4th. Royal Bank of Canada reissued an “outperform” rating and set a $68.00 price objective on shares of CVS Health in a research report on Wednesday, September 4th. Wells Fargo & Company upped their target price on shares of CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research report on Monday, August 12th. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. Ten analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $74.05.

CVS Health Stock Down 0.8 %

CVS traded down $0.54 on Wednesday, reaching $65.36. The company’s stock had a trading volume of 2,578,965 shares, compared to its average volume of 10,990,032. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The stock has a 50 day moving average of $58.72 and a two-hundred day moving average of $61.16. The company has a market capitalization of $82.05 billion, a price-to-earnings ratio of 11.58, a P/E/G ratio of 0.81 and a beta of 0.54.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping the consensus estimate of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The firm had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same period last year, the business earned $2.21 EPS. CVS Health’s revenue for the quarter was up 2.6% compared to the same quarter last year. As a group, analysts forecast that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 4.07%. The ex-dividend date is Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is 46.75%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.